Literature DB >> 34706304

Multi-label, multi-domain learning identifies compounding effects of HIV and cognitive impairment.

Jiequan Zhang1, Qingyu Zhao1, Ehsan Adeli1, Adolf Pfefferbaum2, Edith V Sullivan1, Robert Paul3, Victor Valcour4, Kilian M Pohl5.   

Abstract

Older individuals infected by Human Immunodeficiency Virus (HIV) are at risk for developing HIV-Associated Neurocognitive Disorder (HAND), i.e., from reduced cognitive functioning similar to HIV-negative individuals with Mild Cognitive Impairment (MCI) or to Alzheimer's Disease (AD) if more severely affected. Incompletely understood is how brain structure can serve to differentiate cognitive impairment (CI) in the HIV-positive (i.e., HAND) from the HIV-negative cohort (i.e., MCI and AD). To that end, we designed a multi-label classifier that labels the structural magnetic resonance images (MRI) of individuals by their HIV and CI status via two binary variables. Proper training of such an approach traditionally requires well-curated datasets containing large number of samples for each of the corresponding four cohorts (healthy controls, CI HIV-negative adults a.k.a. CI-only, HIV-positive patients without CI a.k.a. HIV-only, and HAND). Because of the rarity of such datasets, we proposed to improve training of the multi-label classifier via a multi-domain learning scheme that also incorporates domain-specific classifiers on auxiliary single-label datasets specific to either binary label. Specifically, we complement the training dataset of MRIs of the four cohorts (Control: 156, CI-only: 335, HIV-only: 37, HAND: 145) acquired by the Memory and Aging Center at the University of California - San Francisco with a CI-specific dataset only containing MRIs of HIV-negative subjects (Controls: 229, CI-only: 397) from the Alzheimer's Disease Neuroimaging Initiative and an HIV-specific dataset (Controls: 75, HIV-only: 75) provided by SRI International. Based on cross-validation on the UCSF dataset, the multi-domain and multi-label learning strategy leads to superior classification accuracy compared with one-domain or multi-class learning approaches, specifically for the undersampled HIV-only cohort. The 'prediction logits' of CI computed by the multi-label formulation also successfully stratify motor performance among the HIV-positive subjects (including HAND). Finally, brain patterns driving the subject-level predictions across all four cohorts characterize the independent and compounding effects of HIV and CI in the HAND cohort.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’S disease; HIV-associated neurocognitive disorder; MRI; Multi-domain learning; Multi-label classification

Mesh:

Year:  2021        PMID: 34706304      PMCID: PMC8678333          DOI: 10.1016/j.media.2021.102246

Source DB:  PubMed          Journal:  Med Image Anal        ISSN: 1361-8415            Impact factor:   8.545


  48 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

3.  Mapping cerebellar degeneration in HIV/AIDS.

Authors:  Andrea D Klunder; Ming-Chang Chiang; Rebecca A Dutton; Sharon E Lee; Arthur W Toga; Oscar L Lopez; Howard J Aizenstein; James T Becker; Paul M Thompson
Journal:  Neuroreport       Date:  2008-11-19       Impact factor: 1.837

4.  Dissociable Contributions of Precuneus and Cerebellum to Subjective and Objective Neuropathy in HIV.

Authors:  Natalie M Zahr; Kilian M Pohl; Adolf Pfefferbaum; Edith V Sullivan
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-11       Impact factor: 4.147

5.  Accelerated and Premature Aging Characterizing Regional Cortical Volume Loss in Human Immunodeficiency Virus Infection: Contributions From Alcohol, Substance Use, and Hepatitis C Coinfection.

Authors:  Adolf Pfefferbaum; Natalie M Zahr; Stephanie A Sassoon; Dongjin Kwon; Kilian M Pohl; Edith V Sullivan
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-07-04

6.  HIV-Associated Neurocognitive Disorder (HAND) and the Prospect of Brain-Penetrating Protease Inhibitors for Antiretroviral Treatment.

Authors:  Arun K Ghosh; Anindya Sarkar; Hiroaki Mitsuya
Journal:  Med Res Arch       Date:  2017-04-15

7.  The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Authors:  Clifford R Jack; Matt A Bernstein; Nick C Fox; Paul Thompson; Gene Alexander; Danielle Harvey; Bret Borowski; Paula J Britson; Jennifer L Whitwell; Chadwick Ward; Anders M Dale; Joel P Felmlee; Jeffrey L Gunter; Derek L G Hill; Ron Killiany; Norbert Schuff; Sabrina Fox-Bosetti; Chen Lin; Colin Studholme; Charles S DeCarli; Gunnar Krueger; Heidi A Ward; Gregory J Metzger; Katherine T Scott; Richard Mallozzi; Daniel Blezek; Joshua Levy; Josef P Debbins; Adam S Fleisher; Marilyn Albert; Robert Green; George Bartzokis; Gary Glover; John Mugler; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

8.  Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS.

Authors:  Wei Tu; Patricia A Chen; Noshin Koenig; Daniela Gomez; Esther Fujiwara; M John Gill; Linglong Kong; Christopher Power
Journal:  J Neurovirol       Date:  2019-09-13       Impact factor: 2.643

Review 9.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

10.  Deep learning identifies morphological determinants of sex differences in the pre-adolescent brain.

Authors:  Ehsan Adeli; Qingyu Zhao; Natalie M Zahr; Aimee Goldstone; Adolf Pfefferbaum; Edith V Sullivan; Kilian M Pohl
Journal:  Neuroimage       Date:  2020-08-22       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.